Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely us

Related Keywords

Mumbai ,Maharashtra ,India ,Teneligliptin Remogliflozin ,Alok Malik ,Teneligliptin Pioglitazone ,Group Vice Presidenthead ,Biosimilars Companies ,Glenmark Pharmaceuticals Limited ,Glenmark Pharmaceuticals ,International Diabetes Federation ,Glenmark Pharmaceuticals Ltd ,Dipeptidyl Peptidase ,Zita Plus Pio ,India Formulations ,Drug Controller General ,Pharmaceutical Sales ,Dow Jones Sustainability Index ,